Clinical Trials Logo

Congenital Abnormalities clinical trials

View clinical trials related to Congenital Abnormalities.

Filter by:

NCT ID: NCT00943189 Recruiting - Fetal Anomalies Clinical Trials

Fetal Anomalies Scan at the Time of Nuchal Translucency Study

Start date: June 2008
Phase: N/A
Study type: Observational

Purpose: Fetal anomalies scan at the time of Nuchal Translucency (NT) study.

NCT ID: NCT00909415 Completed - Clinical trials for Anorectal Malformation

Urodynamic Evaluation in Patients With Anorectal Malformation According to Spinal Cord Abnormalities

Start date: May 2009
Phase: N/A
Study type: Observational

This study will examine the effects of spinal cord abnormalities on perioperative neurovesical dysfunction in patients with anorectal abnormalities.

NCT ID: NCT00906737 Completed - Multiple Sclerosis Clinical Trials

Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait Abnormalities

Start date: April 2009
Phase: N/A
Study type: Interventional

This study is being done to test the possible benefits of task-specific focused ankle training using the Ankle-Bot on subjects with Multiple Sclerosis who have "foot-drop." The study also compares the effectiveness of task-specific focused ankle training using the Ankle-Bot with conventional focused ankle therapy in improving the gait of subjects with MS.

NCT ID: NCT00891852 Recruiting - Clinical trials for Down Syndrome (Trisomy 21)

Non-Invasive Determination of Fetal Chromosome Abnormalities

Start date: January 2009
Phase: N/A
Study type: Observational

The overall significance of this study is to develop a laboratory developed test (LDT) to use a new marker in the maternal blood to better identify pregnancies that have a child with a chromosome abnormality such as Down syndrome (trisomy 21), Edward's syndrome (trisomy 18), Patau syndrome (trisomy 13), Klinefelter syndrome, (47, XXY), and other chromosome abnormalities. Accomplishing that task would reduce the need for invasive amniocentesis and CVS procedures.

NCT ID: NCT00881686 Completed - Clinical trials for Heart Defects, Congenital

Myocardial Protection With Adenosine Preconditioning

Start date: June 2008
Phase: Phase 1/Phase 2
Study type: Interventional

Adenosine has been proved to be an important mediator of myocardial protection induced by ischemic preconditioning. The hypothesis of this study is that adenosine preconditioning can provide additional myocardial protection in the setting of pediatric open heart surgery with cardioplegia and cardiopulmonary bypass.

NCT ID: NCT00866827 Completed - Clinical trials for Lymphatic Malformations

Airway Vascular Lesions

Start date: December 2002
Phase:
Study type: Observational

Controversy exists in the treatment of airway hemangiomas ranging from tracheotomy, various lasers, to open removal, none of which have proven to be a gold standard. Venous malformations of the airway are difficult to treat and also require laser therapy or open removal and often repeated treatments are required. Similarly airway lymphatic malformations can require multiple treatment modalities as well as multiple procedures and are infrequently eradicated when extensive. New uses for various lasers and differing treatment protocols are frequently developed. Review of the treatment modalities and efficacy of these methods is required. The goal of this research is to determine protocols for treatment of airway vascular malformation and to evaluate our results from treatment of these lesions.

NCT ID: NCT00857662 Completed - Clinical trials for Brain Arteriovenous Malformations

Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)

Start date: May 2001
Phase: Phase 2
Study type: Interventional

Test whether AVMs treated with Onyx is equivalent to treatment with n-BCA. Success is defined as an AVM size reduction greater than 50%

NCT ID: NCT00849888 Terminated - DiGeorge Anomaly Clinical Trials

Serum-Free Thymus Transplantation in DiGeorge Anomaly

SerumFree
Start date: April 2008
Phase: Phase 1
Study type: Interventional

The study purpose is to determine if thymus tissue cultured in a serum-free (SF) solution is a safe and effective treatment for atypical and typical complete DiGeorge anomaly. [Funding Source - FDA OOPD]

NCT ID: NCT00844129 Completed - Clinical trials for Neurofibromatosis Type 1

Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)

Spine
Start date: December 2006
Phase:
Study type: Observational

The purpose of this study is to determine the incidence and clinical history of neurofibromatosis type 1-related spinal abnormalities.

NCT ID: NCT00833703 Completed - Clinical trials for Heart Defects, Congenital

Long Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation

CLARINET LT
Start date: January 2009
Phase: Phase 3
Study type: Interventional

This study is the extension of the CLARINET study [NCT00396877 -EFC5314] in neonates or infants with cyanotic congenital heart disease palliated with a systemic-to-pulmonary artery shunt. The primary objective was to assess the safety up to 18 months of age of the extended use of Clopidogrel 0.2 mg/kg/day in patients for whom the shunt was still in place at one year of age. The secondary objective was to assess the efficacy on the occurrence of shunt thrombosis requiring intervention or any death.